Logo image of AADI

AADI BIOSCIENCE INC (AADI) Stock Price, Quote, News and Overview

NASDAQ:AADI - Nasdaq - US00032Q1040 - Common Stock - Currency: USD

2.05  -0.05 (-2.38%)

After market: 2.06 +0.01 (+0.49%)

AADI Quote, Performance and Key Statistics

AADI BIOSCIENCE INC

NASDAQ:AADI (3/18/2025, 8:20:08 PM)

After market: 2.06 +0.01 (+0.49%)

2.05

-0.05 (-2.38%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High3.81
52 Week Low1.21
Market Cap94.85M
Shares46.27M
Float43.33M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-06 2025-05-06/bmo
IPO06-26 2018-06-26


AADI short term performance overview.The bars show the price performance of AADI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

AADI long term performance overview.The bars show the price performance of AADI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AADI is 2.05 USD. In the past month the price decreased by -24.07%. In the past year, price decreased by -5.96%.

AADI BIOSCIENCE INC / AADI Daily stock chart

AADI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19 345.13B
AMGN AMGEN INC 14.68 156.41B
GILD GILEAD SCIENCES INC 13.76 132.82B
VRTX VERTEX PHARMACEUTICALS INC 1756.9 130.98B
REGN REGENERON PHARMACEUTICALS 13.51 65.46B
ARGX ARGENX SE - ADR 339.55 39.39B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 34.24B
ONC BEIGENE LTD-ADR N/A 28.00B
BNTX BIONTECH SE-ADR N/A 25.04B
NTRA NATERA INC N/A 20.40B
SMMT SUMMIT THERAPEUTICS INC N/A 17.79B
BIIB BIOGEN INC 7.35 17.72B

About AADI

Company Profile

AADI logo image Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 53 full-time employees. The company went IPO on 2018-06-26. The firm is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.

Company Info

AADI BIOSCIENCE INC

17383 Sunset Avenue, Suite A250

Pacific Palisades CALIFORNIA US

CEO: Joseph Gardner

Employees: 53

Company Website: https://aadibio.com/

Investor Relations: https://ir.aadibio.com/

Phone: 14244738055

AADI BIOSCIENCE INC / AADI FAQ

What is the stock price of AADI BIOSCIENCE INC today?

The current stock price of AADI is 2.05 USD. The price decreased by -2.38% in the last trading session.


What is the ticker symbol for AADI BIOSCIENCE INC stock?

The exchange symbol of AADI BIOSCIENCE INC is AADI and it is listed on the Nasdaq exchange.


On which exchange is AADI stock listed?

AADI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AADI BIOSCIENCE INC stock?

8 analysts have analysed AADI and the average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05. Check the AADI BIOSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AADI BIOSCIENCE INC worth?

AADI BIOSCIENCE INC (AADI) has a market capitalization of 94.85M USD. This makes AADI a Micro Cap stock.


How many employees does AADI BIOSCIENCE INC have?

AADI BIOSCIENCE INC (AADI) currently has 53 employees.


What are the support and resistance levels for AADI BIOSCIENCE INC (AADI) stock?

AADI BIOSCIENCE INC (AADI) has a support level at 1.97 and a resistance level at 2.11. Check the full technical report for a detailed analysis of AADI support and resistance levels.


Is AADI BIOSCIENCE INC (AADI) expected to grow?

The Revenue of AADI BIOSCIENCE INC (AADI) is expected to decline by -46.53% in the next year. Check the estimates tab for more information on the AADI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AADI BIOSCIENCE INC (AADI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AADI BIOSCIENCE INC (AADI) stock pay dividends?

AADI does not pay a dividend.


When does AADI BIOSCIENCE INC (AADI) report earnings?

AADI BIOSCIENCE INC (AADI) will report earnings on 2025-05-06, before the market open.


What is the Price/Earnings (PE) ratio of AADI BIOSCIENCE INC (AADI)?

AADI BIOSCIENCE INC (AADI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.35).


AADI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AADI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AADI. While AADI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AADI Financial Highlights

Over the last trailing twelve months AADI reported a non-GAAP Earnings per Share(EPS) of -2.35. The EPS increased by 3.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -71.98%
ROE -89.57%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-11.67%
Sales Q2Q%14.43%
EPS 1Y (TTM)3.69%
Revenue 1Y (TTM)N/A

AADI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 48% to AADI. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 71.14% and a revenue growth -46.53% for AADI


Ownership
Inst Owners61.01%
Ins Owners11.42%
Short Float %N/A
Short RatioN/A
Analysts
Analysts47.5
Price Target3.06 (49.27%)
EPS Next Y71.14%
Revenue Next Year-46.53%